Reply from authors re: Cora N. Sternberg, Richard Sylvester. Thoughts on a systematic review and meta-analysis of adjuvant chemotherapy in muscle-invasive bladder cancer. Eur Urol 2014;66:55-6

Affiliations

¹ Division of Urology and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
² Bladder Cancer Center, Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. Electronic address: Joaquim_bellmunt@dfci.harvard.edu.

Comment

Jeffrey J Leow et al. Eur Urol. 2014 Jul.

. 2014 Jul;66(1):57-8.

doi: 10.1016/j.eururo.2014.02.006. Epub 2014 Feb 14.

¹ Division of Urology and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
² Bladder Cancer Center, Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. Electronic address: Joaquim_bellmunt@dfci.harvard.edu.

No abstract available

Comment on

Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials.
Leow JJ, Martin-Doyle W, Rajagopal PS, Patel CG, Anderson EM, Rothman AT, Cote RJ, Urun Y, Chang SL, Choueiri TK, Bellmunt J. Leow JJ, et al. Eur Urol. 2014 Jul;66(1):42-54. doi: 10.1016/j.eururo.2013.08.033. Epub 2013 Aug 28. Eur Urol. 2014. PMID: 24018020
Thoughts on a systematic review and meta-analysis of adjuvant chemotherapy in muscle-invasive bladder cancer.
Sternberg CN, Sylvester R. Sternberg CN, et al. Eur Urol. 2014 Jul;66(1):55-6. doi: 10.1016/j.eururo.2014.01.008. Epub 2014 Jan 23. Eur Urol. 2014. PMID: 24484605 No abstract available.